✦ LIBER ✦

The proliferation of bladder cancer cells is inhibited by antisense oligonucleotides directed against transforming growth factor α

Book ID: 116104945
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 72 KB
Volume: 64
Category: Article
ISSN: 0167-0115
DOI: 10.1016/0167-0115(96)88077-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of the proliferative effect o

Inhibition of the proliferative effect of transforming growth factor-α by c-myc antisense DNA in human ovarian cancer cells

✍ Hae-Young Park 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

Treatment of the T98G glioblastoma cell

Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-α and the epidermal growth factor receptor

✍ Marvin Rubenstein; Roberta Glick; Terry Lichtor; Yelena Mirochnik; Pauline Chou; 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 305 KB

The antiproliferative effect of suramin

The antiproliferative effect of suramin on the cancer cell line sw-13 is mediated by the inhibition of transforming growth factor β1 (TGF-β1)☆

✍ DANESI, R; AGEN, C; BERNARDINI, N; COSTA, M; DELTACCA, M 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant